MedClips™ Profile

Androgen Ablation Oliver Sartor, MD, Director, Stanley Scott Cancer Center, Chief, Hematology and Oncology, Louisiana State University School of Medicine, New Orleans, discusses three prostate-cancer scenarios where hormonal therapy has been shown to extend survival. He emphasizes that the use of hormones early in a treatment regimen seems to maximize benefit. He also talks about the many new hormonal agents being developed for prostate cancer, including GnRH antagonists and long-acting LHRH agonists. Speaker: Oliver Sartor, MD Affiliation: Stanley Scott Cancer Center, Louisiana State University School of Medicine Duration: 35 Minute(s), 0 Seconds(s) Location: New Orleans, LA

<<Back

System Requirements   This Web site takes advantage of the latest Internet technology to bring you the most cutting-edge information on cancer. The MedClip Lectures require the RealOne Player or later version for audio/video. We recommend you install the latest version of the free plug-in before viewing the MedClipsTM.

Download and install RealOne Player or later version (Required) Note: To get a FREE version of RealOne Player, you must click on "Free RealOne Player" which is located at the top right-hand corner of the RealNetwork Web site and not on the "free 14-day trial version." or read the easy download and setup/installation instructions. Contact Technical Support if you experience any technical difficulties.